Cognitive genomics

Last updated

Cognitive genomics (or neurative genomics) is the sub-field of genomics pertaining to cognitive function in which the genes and non-coding sequences of an organism's genome related to the health and activity of the brain are studied. By applying comparative genomics, the genomes of multiple species are compared in order to identify genetic and phenotypical differences between species. Observed phenotypical characteristics related to the neurological function include behavior, personality, neuroanatomy, and neuropathology. The theory behind cognitive genomics is based on elements of genetics, evolutionary biology, molecular biology, cognitive psychology, behavioral psychology, and neurophysiology.

Contents

Intelligence is the most extensively studied behavioral trait. [1] In humans, approximately 70% of all genes are expressed in the brain. [2] Genetic variation accounts for 40% of phenotypical variation. [3] Approaches in cognitive genomics have been used to investigate the genetic causes for many mental and neurodegenerative disorders including Down syndrome, major depressive disorder, autism, and Alzheimer's disease.

Cognitive genomics testing

Approaches

Evo-geno

The most commonly used approach to genome-investigation is evolutionary genomics biology, or evo-geno, in which the genomes of two species which share a common ancestor are compared. [4] A common example of evo-geno is comparative cognitive genomics testing between humans and chimpanzees which shared an ancestor 6-7 million years ago. [5] Patterns in local gene expression and gene splicing are examined to determine genomic differentiation. Comparative transcriptomic analyses conducted on primate brains to measure gene expression levels have shown significant differences between human and chimpanzee genomes. [4] The evo-geno approach was also used to verify the theory that humans and non-human primates share similar expression levels in energy metabolism-related genes which have implications for aging and neurodegenerative disease. [4]

Evo-devo

Evolutionary development biology (evo-devo) approach compares cognitive and neuroanatomic development patterns between sets of species. Studies of human fetus brains reveal that almost a third of expressed genes are regionally differentiated, far more than non-human species. [4] This finding could potentially explain variations in cognitive development between individuals. Neuroanatomical evo-devo studies have connected higher brain order to brain lateralization which, though present in other species, is highly ordered in humans.

Evo-pheno and evo-patho

Evolutionary phenotype biology (evo-pheno) approach examines phenotype expression between species. Evolutionary pathology biology (evo-patho) approach investigates disease prevalence between species.

Imaging genomics

Candidate gene selection

In genomics, a gene being imaged and analyzed is referred to as a candidate gene. The ideal candidate genes for comparative genomic testing are genes that harbor well-defined functional polymorphisms with known effects on neuroanatomical and/or cognitive function. [2] However, genes with either identified single-nucleotide polymorphisms or allele variations with potential functional implications on neuroanatomical systems suffice. [2] The weaker the connection between the gene and the phenotype, the more difficult it is to establish causality through testing. [2]

Controlling for non-genetic factors

Non-genetic factors such as age, illness, injury, or substance abuse can have significant effects on gene expression and phenotypic variance. [2] The identification and contribution of genetic variation to specific phenotypes can only be performed when other potential contributing factors can be matched across genotype groups. [2] In the case of neuroimaging during task performance such as in fMRI, groups are matched by performance level. Non-genetic factors have a particularly large potential effect on cognitive development. In the case of autism, non-genetic factors account for 62% of disease risk. [6]

Task selection

In order to study the connection between a candidate gene and a proposed phenotype, a subject is often given a task to perform that elicits the behavioral phenotype while undergoing some form of neuroimaging. Many behavioral tasks used for genomic studies are modified versions of classic behavioral and neuropsychological tests designed to investigate neural systems critical to particular behaviors. [2]

Species used in comparative cognitive genomics

Humans

In 2003, the Human Genome Project produced the first complete human genome. [7] Despite the project's success, very little is known about cognitive gene expression. [8] Prior to 2003, any evidence concerning human brain connectivity was based on post-mortem observations. [9] Due to ethical concerns, no invasive in vivo genomics studies have been performed on live humans.[ citation needed ]

Non-human primates

As the closest genetic relatives to humans, non-human primates are the most preferable genomics imaging subjects. In most cases, primates are imaged while under anesthesia. [8] Due to the high cost of raising and maintaining primate populations, genomic testing on non-human primates is typically performed at primate research facilities.

Chimpanzees

Chimpanzees ( Pan troglodytes ) are the closest genetic relatives to humans, sharing 93.6% genetic similarity. [10] It is believed that humans and chimpanzees shared a common genetic ancestor around 7 million years ago. [8] The movement to sequence the chimpanzee genome began in 1998 and was given high priority by the US National Institutes of Health (NIH). [11]

Currently, human and chimpanzees have the only sequenced genomes in the extended family of primates. [12] Some comparisons of autosomal intergenic non-repetitive DNA segments suggest as little as 1.24% genetic difference between humans and chimpanzees along certain sections. [13] Despite the genetic similarity, 80% of proteins between the two species are different which understates the clear phenotypical differences. [14]

Rhesus macaques

Rhesus macaques (Macaca mulatta) exhibit a 93% genetic similarity to humans approximately. [15] They are often used as an out-group in human/chimpanzee genomic studies. [8] Humans and rhesus macaques shared a common ancestor an estimated 25 million years ago. [5]

Apes

Orangutans ( Pongo pygmaeus ) and gorillas ( Gorilla gorilla ) have been used in genomics testing but are not common subjects due to cost. [8]

Neurobehavioral and cognitive disorders

Despite what is sometimes reported, most behavioral or pathological phenotypes are not due to a single gene mutation but rather a complex genetic basis. [16] However, there are some exceptions to this rule such as Huntington's disease which is caused by a single specific genetic disorder. [16] The occurrence of neurobehavioral disorders is influenced by a number of factors, genetic and non-genetic.

Down syndrome

Down syndrome is a genetic syndrome marked by intellectual disability and distinct cranio-facial features and occurs in approximately 1 in 800 live births. [17] Experts believe the genetic cause for the syndrome is a lack of genes in the 21st chromosome. [17] However, the gene or genes responsible for the cognitive phenotype have yet to be discovered.

Fragile-X syndrome

Fragile-X syndrome is caused by a mutation of the FRAXA gene located in the X chromosome. [17] The syndrome is marked by intellectual disability (moderate in males, mild in females), language deficiency, and some autistic spectrum behaviors. [17]

Alzheimer's disease

Alzheimer's disease is a neurodegenerative disorder that causes age-correlated progressive cognitive decline. [17] animal model using mice have investigated the pathophysiology and suggest possible treatments such as immunization with amyloid beta and peripheral administration of antibodies against amyloid beta. [17] Studies have linked Alzheimer's with gene alterations causing SAMP8 protein abnormalities. [18]

Autism

Autism is a pervasive developmental disorder characterized by abnormal social development, inability to empathize and effectively communicate, and restricted patterns of interest. [17] A possible neuroanatomical cause is the presence of tubers in the temporal lobe. [17] As mentioned previously, non-genetic factors account for 62% of autism development risk. [6] Autism is a human-specific disorder. As such, the genetic cause has been implicated to highly ordered brain lateralization exhibited by humans. [4] Two genes have been linked to autism and autism spectrum disorders (ASD): c3orf58 (a.k.a. Deleted In Autism-1 or DIA1) and cXorf36 (a.k.a.Deleted in Autism-1 Related or DIA1R). [19]

Major depressive disorder

Major depressive disorder is a common mood disorder believed to be caused by irregular neural uptake of serotonin. While the genetic cause is unknown, genomic studies of post-mortem MDD brains have discovered abnormalities in the fibroblast growth factor system which supports the theory of growth factors playing an important role in mood disorders. [20]

Others

Other neurodegenerative disorders include Rett syndrome, Prader–Willi syndrome, Angelman syndrome, and Williams-Beuren syndrome.

See also

Related Research Articles

Genomic imprinting is an epigenetic phenomenon that causes genes to be expressed or not, depending on whether they are inherited from the female or male parent. Genes can also be partially imprinted. Partial imprinting occurs when alleles from both parents are differently expressed rather than complete expression and complete suppression of one parent's allele. Forms of genomic imprinting have been demonstrated in fungi, plants and animals. In 2014, there were about 150 imprinted genes known in mice and about half that in humans. As of 2019, 260 imprinted genes have been reported in mice and 228 in humans.

<span class="mw-page-title-main">Phenotype</span> Composite of the organisms observable characteristics or traits

In genetics, the phenotype is the set of observable characteristics or traits of an organism. The term covers the organism's morphology, its developmental processes, its biochemical and physiological properties, its behavior, and the products of behavior. An organism's phenotype results from two basic factors: the expression of an organism's genetic code and the influence of environmental factors. Both factors may interact, further affecting the phenotype. When two or more clearly different phenotypes exist in the same population of a species, the species is called polymorphic. A well-documented example of polymorphism is Labrador Retriever coloring; while the coat color depends on many genes, it is clearly seen in the environment as yellow, black, and brown. Richard Dawkins in 1978 and then again in his 1982 book The Extended Phenotype suggested that one can regard bird nests and other built structures such as caddisfly larva cases and beaver dams as "extended phenotypes".

<span class="mw-page-title-main">Human genome</span> Complete set of nucleic acid sequences for humans

The human genome is a complete set of nucleic acid sequences for humans, encoded as DNA within the 23 chromosome pairs in cell nuclei and in a small DNA molecule found within individual mitochondria. These are usually treated separately as the nuclear genome and the mitochondrial genome. Human genomes include both protein-coding DNA sequences and various types of DNA that does not encode proteins. The latter is a diverse category that includes DNA coding for non-translated RNA, such as that for ribosomal RNA, transfer RNA, ribozymes, small nuclear RNAs, and several types of regulatory RNAs. It also includes promoters and their associated gene-regulatory elements, DNA playing structural and replicatory roles, such as scaffolding regions, telomeres, centromeres, and origins of replication, plus large numbers of transposable elements, inserted viral DNA, non-functional pseudogenes and simple, highly repetitive sequences. Introns make up a large percentage of non-coding DNA. Some of this non-coding DNA is non-functional junk DNA, such as pseudogenes, but there is no firm consensus on the total amount of junk DNA.

<span class="mw-page-title-main">FOXP2</span> Transcription factor gene of the forkhead box family

Forkhead box protein P2 (FOXP2) is a protein that, in humans, is encoded by the FOXP2 gene. FOXP2 is a member of the forkhead box family of transcription factors, proteins that regulate gene expression by binding to DNA. It is expressed in the brain, heart, lungs and digestive system.

<span class="mw-page-title-main">Pleiotropy</span> Influence of a single gene on multiple phenotypic traits

Pleiotropy occurs when one gene influences two or more seemingly unrelated phenotypic traits. Such a gene that exhibits multiple phenotypic expression is called a pleiotropic gene. Mutation in a pleiotropic gene may have an effect on several traits simultaneously, due to the gene coding for a product used by a myriad of cells or different targets that have the same signaling function.

<span class="mw-page-title-main">Human genetics</span> Study of inheritance as it occurs in human beings

Human genetics is the study of inheritance as it occurs in human beings. Human genetics encompasses a variety of overlapping fields including: classical genetics, cytogenetics, molecular genetics, biochemical genetics, genomics, population genetics, developmental genetics, clinical genetics, and genetic counseling.

<span class="mw-page-title-main">Heritability of autism</span>

The heritability of autism is the proportion of differences in expression of autism that can be explained by genetic variation; if the heritability of a condition is high, then the condition is considered to be primarily genetic. Autism has a strong genetic basis. Although the genetics of autism are complex, autism spectrum disorder (ASD) is explained more by multigene effects than by rare mutations with large effects.

<span class="mw-page-title-main">Causes of autism</span> Proposed causes of autism

Many causes of autism, including environmental and genetic factors, have been recognized or proposed, but understanding of the theory of causation of autism is incomplete. Attempts have been made to incorporate the known genetic and environmental causes into a comprehensive causative framework. ASD is a neurodevelopmental disorder marked by impairments in communicative ability and social interaction and restricted/repetitive behaviors, interests, or activities not suitable for the individual's developmental stage. The severity of symptoms and functional impairment vary between individuals.

<span class="mw-page-title-main">22q13 deletion syndrome</span> Rare genetic syndrome

22q13 deletion syndrome, also known as Phelan–McDermid syndrome (PMS), is a genetic disorder caused by deletions or rearrangements on the q terminal end of chromosome 22. Any abnormal genetic variation in the q13 region that presents with significant manifestations (phenotype) typical of a terminal deletion may be diagnosed as 22q13 deletion syndrome. There is disagreement among researchers as to the exact definition of 22q13 deletion syndrome. The Developmental Synaptopathies Consortium defines PMS as being caused by SHANK3 mutations, a definition that appears to exclude terminal deletions. The requirement to include SHANK3 in the definition is supported by many but not by those who first described 22q13 deletion syndrome.

Human evolutionary genetics studies how one human genome differs from another human genome, the evolutionary past that gave rise to the human genome, and its current effects. Differences between genomes have anthropological, medical, historical and forensic implications and applications. Genetic data can provide important insights into human evolution.

The Olduvai domain, known until 2018 as DUF1220 and the NBPF repeat, is a protein domain that shows a striking human lineage-specific (HLS) increase in copy number and appears to be involved in human brain evolution. The protein domain has also been linked to several neurogenetic disorders such as schizophrenia and increased severity of autism. In 2018, it was named by its discoverers after Olduvai Gorge in Tanzania, one of the most important archaeological sites for early humans, to reflect data indicating its role in human brain size and evolution.

<span class="mw-page-title-main">Evolution of the brain</span> Overview of the evolution of the brain

There is much to be discovered about the evolution of the brain and the principles that govern it. While much has been discovered, not everything currently known is well understood. The evolution of the brain has appeared to exhibit diverging adaptations within taxonomic classes such as Mammalia and more vastly diverse adaptations across other taxonomic classes. Brain to body size scales allometrically. This means as body size changes, so do other physiological, anatomical, and biochemical constructs connecting the brain to the body. Small bodied mammals have relatively large brains compared to their bodies whereas large mammals have a smaller brain to body ratios. If brain weight is plotted against body weight for primates, the regression line of the sample points can indicate the brain power of a primate species. Lemurs for example fall below this line which means that for a primate of equivalent size, we would expect a larger brain size. Humans lie well above the line indicating that humans are more encephalized than lemurs. In fact, humans are more encephalized compared to all other primates. This means that human brains have exhibited a larger evolutionary increase in its complexity relative to its size. Some of these evolutionary changes have been found to be linked to multiple genetic factors, such as proteins and other organelles.

<span class="mw-page-title-main">Neurogenetics</span> Study of role of genetics in the nervous system

Neurogenetics studies the role of genetics in the development and function of the nervous system. It considers neural characteristics as phenotypes, and is mainly based on the observation that the nervous systems of individuals, even of those belonging to the same species, may not be identical. As the name implies, it draws aspects from both the studies of neuroscience and genetics, focusing in particular how the genetic code an organism carries affects its expressed traits. Mutations in this genetic sequence can have a wide range of effects on the quality of life of the individual. Neurological diseases, behavior and personality are all studied in the context of neurogenetics. The field of neurogenetics emerged in the mid to late 20th century with advances closely following advancements made in available technology. Currently, neurogenetics is the center of much research utilizing cutting edge techniques.

Potocki–Lupski syndrome (PTLS), also known as dup(17)p11.2p11.2 syndrome, trisomy 17p11.2 or duplication 17p11.2 syndrome, is a contiguous gene syndrome involving the microduplication of band 11.2 on the short arm of human chromosome 17 (17p11.2). The duplication was first described as a case study in 1996. In 2000, the first study of the disease was released, and in 2007, enough patients had been gathered to complete a comprehensive study and give it a detailed clinical description. PTLS is named for two researchers involved in the latter phases, Drs. Lorraine Potocki and James R. Lupski of Baylor College of Medicine.

<span class="mw-page-title-main">Neurogenomics</span>

Neurogenomics is the study of how the genome of an organism influences the development and function of its nervous system. This field intends to unite functional genomics and neurobiology in order to understand the nervous system as a whole from a genomic perspective.

1q21.1 deletion syndrome is a rare aberration of chromosome 1. A human cell has one pair of identical chromosomes on chromosome 1. With the 1q21.1 deletion syndrome, one chromosome of the pair is not complete, because a part of the sequence of the chromosome is missing. One chromosome has the normal length and the other is too short.

<span class="mw-page-title-main">1q21.1 duplication syndrome</span> Medical condition

1q21.1 duplication syndrome or 1q21.1 (recurrent) microduplication is a rare aberration of chromosome 1.

<span class="mw-page-title-main">Imprinted brain hypothesis</span> Conjecture on the causes of autism and psychosis

The imprinted brain hypothesis is an unsubstantiated hypothesis in evolutionary psychology regarding the causes of autism spectrum and schizophrenia spectrum disorders, first presented by Bernard Crespi and Christopher Badcock in 2008. It claims that certain autistic and schizotypal traits are opposites, and that this implies the etiology of the two conditions must be at odds.

Autism spectrum disorder (ASD) refers to a variety of conditions typically identified by challenges with social skills, communication, speech, and repetitive sensory-motor behaviors. The 11th International Classification of Diseases (ICD-11), released in January 2021, characterizes ASD by the associated deficits in the ability to initiate and sustain two-way social communication and restricted or repetitive behavior unusual for the individual's age or situation. Although linked with early childhood, the symptoms can appear later as well. Symptoms can be detected before the age of two and experienced practitioners can give a reliable diagnosis by that age. However, official diagnosis may not occur until much older, even well into adulthood. There is a large degree of variation in how much support a person with ASD needs in day-to-day life. This can be classified by a further diagnosis of ASD level 1, level 2, or level 3. Of these, ASD level 3 describes people requiring very substantial support and who experience more severe symptoms. ASD-related deficits in nonverbal and verbal social skills can result in impediments in personal, family, social, educational, and occupational situations. This disorder tends to have a strong correlation with genetics along with other factors. More research is identifying ways in which epigenetics is linked to autism. Epigenetics generally refers to the ways in which chromatin structure is altered to affect gene expression. Mechanisms such as cytosine regulation and post-translational modifications of histones. Of the 215 genes contributing, to some extent in ASD, 42 have been found to be involved in epigenetic modification of gene expression. Some examples of ASD signs are specific or repeated behaviors, enhanced sensitivity to materials, being upset by changes in routine, appearing to show reduced interest in others, avoiding eye contact and limitations in social situations, as well as verbal communication. When social interaction becomes more important, some whose condition might have been overlooked suffer social and other exclusion and are more likely to have coexisting mental and physical conditions. Long-term problems include difficulties in daily living such as managing schedules, hypersensitivities, initiating and sustaining relationships, and maintaining jobs.

The evolution of schizophrenia refers to the theory of natural selection working in favor of selecting traits that are characteristic of the disorder. Positive symptoms are features that are not present in healthy individuals but appear as a result of the disease process. These include visual and/or auditory hallucinations, delusions, paranoia, and major thought disorders. Negative symptoms refer to features that are normally present but are reduced or absent as a result of the disease process, including social withdrawal, apathy, anhedonia, alogia, and behavioral perseveration. Cognitive symptoms of schizophrenia involve disturbances in executive functions, working memory impairment, and inability to sustain attention.

References

  1. Plomin, Robert; Spinath, Frank M. (January 2004). "Intelligence: Genetics, Genes, and Genomics". Journal of Personality and Social Psychology. 86 (1): 112–129. CiteSeerX   10.1.1.525.3970 . doi:10.1037/0022-3514.86.1.112. PMID   14717631.
  2. 1 2 3 4 5 6 7 Hariri, Ahmad R; Weinberger, Daniel R (March 2003). "Imaging genomics". British Medical Bulletin. 65 (1): 259–270. doi: 10.1093/bmb/65.1.259 . PMID   12697630.
  3. Plomin, Robert; Spinath, Frank M. (January 2004). "Intelligence: Genetics, Genes, and Genomics" (PDF). Journal of Personality and Social Psychology. 86 (1): 112–129. doi:10.1037/0022-3514.86.1.112. PMID   14717631. S2CID   5734393. Archived from the original (PDF) on 2020-07-26.
  4. 1 2 3 4 5 Konopka, Genevieve; Geschwind, Daniel H. (21 October 2010). "Human Brain Evolution: Harnessing the Genomics (R)evolution to Link Genes, Cognition, and Behavior". Neuron. 68 (2): 231–244. doi:10.1016/j.neuron.2010.10.012. PMC   2993319 . PMID   20955931.
  5. 1 2 Cáceres, Mario; Lachuer, Joel; Zapala, Matthew A.; Redmond, John C.; Kudo, Lili; Geschwind, Daniel H.; Lockhart, David J.; Preuss, Todd M.; Barlow, Carrolee (28 October 2003). "Elevated gene expression levels distinguish human from non-human primate brains". Proceedings of the National Academy of Sciences. 100 (22): 13030–13035. Bibcode:2003PNAS..10013030C. doi: 10.1073/pnas.2135499100 . PMC   240739 . PMID   14557539.
  6. 1 2 Digitale, Erin (4 July 2011). "Non-genetic factors play surprisingly large role in determining autism, says study by group". Stanford School of Medicine, Stanford University.
  7. "Human Genome Project FAQ". National Human Genome Research Institute.
  8. 1 2 3 4 5 Interview with Todd Preuss, PhD, Yerkes National Primate Research Center[ unreliable source? ]
  9. Behrens, T E J; Johansen-Berg, H; Woolrich, M W; Smith, S M; Wheeler-Kingshott, C A M; Boulby, P A; Barker, G J; Sillery, E L; Sheehan, K; Ciccarelli, O; Thompson, A J; Brady, J M; Matthews, P M (15 June 2003). "Non-invasive mapping of connections between human thalamus and cortex using diffusion imaging". Nature Neuroscience. 6 (7): 750–757. doi:10.1038/nn1075. PMID   12808459. S2CID   827480.
  10. Cohen, Jon (7 June 2007). "Relative Differences: The Myth of 1%". Science. 316 (5833): 1836. doi:10.1126/science.316.5833.1836. PMID   17600195. S2CID   84106299.
  11. Olson, Maynard V.; Varki, Ajit (January 2003). "Sequencing the chimpanzee genome: insights into human evolution and disease". Nature Reviews Genetics. 4 (1): 20–28. doi:10.1038/nrg981. PMID   12509750. S2CID   205486561.
  12. Goodman, Morris; Grossman, Lawrence I.; Wildman, Derek E. (September 2005). "Moving primate genomics beyond the chimpanzee genome". Trends in Genetics. 21 (9): 511–517. doi:10.1016/j.tig.2005.06.012. PMID   16009448.
  13. Chen, Feng-Chi; Li, Wen-Hsiung (2001). "Genomic Divergences between Humans and Other Hominoids and the Effective Population Size of the Common Ancestor of Humans and Chimpanzees". American Journal of Human Genetics. 68 (2): 444–456. CiteSeerX   10.1.1.329.720 . doi:10.1086/318206. PMC   1235277 . PMID   11170892.
  14. Glazko, Galina; Veeramachaneni, Vamsi; Nei, Masatoshi; Makałowski, Wojciech (February 2005). "Eighty percent of proteins are different between humans and chimpanzees". Gene. 346: 215–219. doi:10.1016/j.gene.2004.11.003. PMID   15716009.
  15. "DNA sequence of Rhesus macaque has evolutionary, medical implications" (Press release). Baylor College of Medicine. 12 April 2007.
  16. 1 2 McGuffin, Peter; Riley, Brien; Plomin, Robert (16 February 2001). "Toward Behavioral Genomics". Science. 291 (5507): 1232–1249. doi:10.1126/science.1057264. PMID   11233447. S2CID   83900633.
  17. 1 2 3 4 5 6 7 8 Fisch, Gene S. (2003). Genetics and Genomics of Neurobehavioral Disorders. Humana Press. pp. 3–19. doi:10.1007/978-1-59259-353-8_1 (inactive 31 January 2024). ISBN   978-1-59259-353-8.{{cite book}}: CS1 maint: DOI inactive as of January 2024 (link)
  18. Butterfield, D; Poon, H (October 2005). "The senescence-accelerated prone mouse (SAMP8): A model of age-related cognitive decline with relevance to alterations of the gene expression and protein abnormalities in Alzheimer's disease". Experimental Gerontology. 40 (10): 774–783. CiteSeerX   10.1.1.313.4638 . doi:10.1016/j.exger.2005.05.007. PMID   16026957. S2CID   15860658.
  19. Aziz, Azhari; Harrop, Sean P.; Bishop, Naomi E. (19 January 2011). "Characterization of the Deleted in Autism 1 Protein Family: Implications for Studying Cognitive Disorders". PLOS ONE. 6 (1): e14547. Bibcode:2011PLoSO...614547A. doi: 10.1371/journal.pone.0014547 . PMC   3023760 . PMID   21283809.
  20. Niculescu, Alexander B (2005). "Genomic studies of mood disorders - the brain as a muscle?". Genome Biology. 6 (4): 215. doi: 10.1186/gb-2005-6-4-215 . PMC   1088952 . PMID   15833130.